The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatology Research Foundation’s Incoming President Shares Vision for Building the Next 30 Years of Growth

Rheumatology Research Foundation’s Incoming President Shares Vision for Building the Next 30 Years of Growth

December 15, 2015 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Calvin Brown Jr., MD, received funding from the Foundation to help train the next generation of rheumatology professionals.

Calvin Brown Jr., MD, received funding from the Foundation to help train the next generation of rheumatology professionals.

Meet the Foundation’s incoming president, Eric L. Matteson, MD, MPH. Dr. Matteson trained in rheumatology at the University of Michigan and Mayo Graduate School of Medicine, Mayo Clinic College of Medicine. He later earned his Master of Public Health in epidemiology at the University of North Carolina, Chapel Hill. Dr. Matteson currently works as the rheumatology chair at Mayo Clinic in Minnesota. His research interests include epidemiology and novel treatments of vasculitis and rheumatoid arthritis, as well as the impact of rheumatoid arthritis on the development of coexisting conditions, such as heart disease. Following is an excerpt of an interview the Foundation conducted with Dr. Matteson as part of the organization’s 30th anniversary celebration. He reflects on his relationship with the Foundation and his plans for his tenure as president.

You Might Also Like
  • Former Foundation President Reflects on 30 Years of Research & Training
  • Maximizing the ACR’s Power: A conversation with Rheumatology Research Foundation President Eric Matteson, MD, MPH
  • Rheumatology Research Foundation Investigators’ Meeting Shares Advancements Toward a Cure
Explore This Issue
December 2015
Also By This Author
  • Rheumatology Research Foundation Names New Executive Director

Q. How has the Foundation affected your career?

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

A. In terms of how the Foundation has affected me, there is a global perspective and a personal perspective. Globally, I’m very committed as a rheumatologist and physician [to] taking care of patients [and] advancing the understanding of our diseases. As the biggest private supporter of rheumatology research in the U.S., everything the Foundation does serves that end and helps me help my patients.

The other, more personal, side is that I am co-recipient of a grant that is now fully in the hands of one of my colleagues due to my role in the Foundation. The grant has allowed us to examine lung disease in rheumatoid arthritis (RA), which is one of the major poorly understood comorbidities affecting patients. It’s difficult to find funding to study these topics, and the Foundation has the vision and the resources for us to undertake this project.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Matteson

We are a lot closer [to a cure now] than we were 30 years ago when the Foundation started its work.

Q. How did you first get involved with the Foundation?

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

A. I first heard about the Foundation when I joined the ACR as a fellow, nearly 30 years ago in 1986. At that time, the Foundation was just getting off the ground. I didn’t know much about it until I got more into my career and got involved with the American College of Rheumatology. I realized the efforts of the Foundation were critical to the success of our workforce development and our research. As rheumatology chair at Mayo Clinic, I look for funding opportunities for our staff—junior staff in particular—to help them with career development and foster the development of workforce in rheumatology. These are things that the Foundation provides resources and infrastructure for. This realization that we are not going to be able to fund or support all of our research and workforce development through the federal government, but rather increasingly need to be knowledgeable about and rely on efforts of the Foundation [and others], got me very engaged with the mission of the Foundation.

Pages: 1 2 3 | Single Page

Filed Under: From the College Tagged With: ACR/ARHP, Association of Rheumatology Professionals (ARP), Eric Matteson, rheumatology, Rheumatology Research FoundationIssue: December 2015

You Might Also Like:
  • Former Foundation President Reflects on 30 Years of Research & Training
  • Maximizing the ACR’s Power: A conversation with Rheumatology Research Foundation President Eric Matteson, MD, MPH
  • Rheumatology Research Foundation Investigators’ Meeting Shares Advancements Toward a Cure
  • Meet Incoming Rheumatology Research Foundation President Abby Abelson, MD, FACR

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)